Estimating protective vaccine efficacy from large trials with recruitment
DOI10.1016/J.JSPI.2006.06.016zbMATH Open1104.62116OpenAlexW2071373257MaRDI QIDQ866637FDOQ866637
Authors: Sergey Utev, Niels G. Becker, Claude Lefèvre 
Publication date: 14 February 2007
Published in: Journal of Statistical Planning and Inference (Search for Journal in Brave)
Full work available at URL: https://doi.org/10.1016/j.jspi.2006.06.016
Recommendations
- scientific article; zbMATH DE number 1741804
- Estimating vaccine efficacy from small outbreaks
- Estimation of vaccine efficacy from epidemics of acute infectious agents under vaccine-related heterogeneity
- On the distribution of vaccine protection under heterogeneous response
- Heterogeneity in disease risk induces falling vaccine protection with rising disease incidence
asymptotic distributionestimationlower and upper boundsrandom vaccine responserecruiting trial participants
Asymptotic properties of parametric estimators (62F12) Applications of statistics to biology and medical sciences; meta analysis (62P10) Medical epidemiology (92C60)
Cites Work
- Epidemics with two levels of mixing
- Stochastic multitype epidemics in a community of households: Estimation of threshold parameter R and secure vaccination coverage
- Estimating vaccine efficacy from small outbreaks
- Approximating the Reed-Frost epidemic process
- Limit theorems for multitype epidemics
- Estimating vaccine effects on transmission of infection from household outbreak data
- On critical vaccination coverage in multitype epidemics
- Title not available (Why is that?)
- Design issues for studies of infectious diseases
Cited In (11)
- On the distribution of vaccine protection under heterogeneous response
- Endpoints in vaccine trials
- Leaky vaccines protect highly exposed recipients at a lower rate: implications for vaccine efficacy estimation and sieve analysis
- Heterogeneity in disease risk induces falling vaccine protection with rising disease incidence
- Discussion on “Estimating vaccine efficacy over time after a randomized study is unblinded” by Anastasios A. Tsiatis and Marie Davidian
- Estimation and interpretation of heterogeneous vaccine efficacy against recurrent infections
- Assessing the effect of an influenza vaccine in an encouragement design
- Estimating strain-specific and overall efficacy of polyvalent vaccines against recurrent pathogens from a cross-sectional study
- Estimating correlations between vaccine clinical trial outcomes
- Estimating Vaccine Efficacy Over Time After a Randomized Study is Unblinded
- Design of vaccine trials during outbreaks with and without a delayed vaccination comparator
This page was built for publication: Estimating protective vaccine efficacy from large trials with recruitment
Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q866637)
